RNA Virus Infections
Information
- Disease name
- RNA Virus Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05284097 | Active, not recruiting | Phase 2 | Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study | September 19, 2022 | May 31, 2024 |
| NCT01244867 | Completed | Phase 2 | Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine | November 2010 | September 2011 |
| NCT01587131 | Completed | Phase 1 | DNA-based Influenza Vaccine in the Elderly | June 2012 | March 2015 |
| NCT01791556 | Completed | N/A | Clinic-based ART Diagnostic Evaluation | January 26, 2010 | August 2012 |
| NCT01991561 | Completed | Phase 2 | Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. | June 2013 | November 2014 |
| NCT01991587 | Completed | Phase 1/Phase 2 | Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults | October 8, 2013 | June 30, 2014 |
| NCT02022163 | Completed | Phase 1 | Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. | December 2013 | December 2014 |
| NCT02233816 | Completed | Phase 2 | Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults | July 28, 2014 | June 22, 2015 |
| NCT02236052 | Completed | Phase 2 | Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population | July 16, 2014 | June 17, 2015 |
| NCT05422326 | Completed | Phase 2 | A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed | July 18, 2022 | March 24, 2023 |
| NCT03739112 | Completed | Phase 3 | Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly | September 18, 2018 | July 16, 2019 |
| NCT04367740 | Completed | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | April 28, 2020 | February 28, 2022 | |
| NCT04476979 | Completed | Phase 2 | Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 | July 16, 2020 | August 11, 2021 |
| NCT04517682 | Completed | COVID-19 and SARS-CoV-2 Detection in Saliva | May 21, 2020 | August 5, 2021 | |
| NCT04644484 | Completed | Phase 3 | A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety | September 23, 2020 | December 16, 2022 |
| NCT04772469 | Completed | N/A | Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men | March 22, 2021 | April 26, 2023 |
| NCT04822818 | Completed | Phase 3 | EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 | April 17, 2021 | July 11, 2022 |
| NCT05065905 | Completed | Phase 1/Phase 2 | Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis | January 19, 2006 | April 6, 2006 |
| NCT05307991 | Completed | Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe | March 9, 2022 | August 1, 2023 | |
| NCT00984945 | Completed | Phase 1 | Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults | September 2009 | July 2010 |
| NCT02630082 | Completed | N/A | Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru | April 2011 | March 2013 |
| NCT02768805 | Completed | Phase 2 | Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults | March 2, 2016 | November 26, 2016 |
| NCT02831751 | Completed | Phase 2 | Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults | April 2016 | January 2017 |
| NCT03110770 | Completed | Phase 2 | VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents | March 29, 2017 | October 4, 2019 |
| NCT03294473 | Completed | N/A | Centralized Reminder Recall - Flu RCT2 | October 18, 2017 | May 4, 2018 |
| NCT03301051 | Completed | Phase 3 | Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults | August 31, 2017 | May 9, 2018 |
| NCT03321968 | Completed | Phase 3 | Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults | September 29, 2017 | December 1, 2017 |
| NCT03392207 | Completed | Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) | April 23, 2018 | September 14, 2018 | |
| NCT03642977 | Completed | DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients | March 1, 2017 | December 31, 2020 | |
| NCT05394623 | Not yet recruiting | Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study) | November 1, 2022 | July 1, 2023 | |
| NCT04376034 | Recruiting | Phase 3 | Convalescent Plasma Collection and Treatment in Pediatrics and Adults | April 16, 2020 | March 30, 2021 |
| NCT02120274 | Terminated | Phase 4 | Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C | March 2014 | May 2016 |
| NCT02613403 | Terminated | Phase 2 | Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) | December 10, 2015 | March 27, 2017 |
| NCT04664075 | Terminated | Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) | January 25, 2021 | April 30, 2022 | |
| NCT04627623 | Unknown status | Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration | June 22, 2020 | April 22, 2021 | |
| NCT03776760 | Unknown status | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination | May 28, 2019 | August 2022 | |
| NCT04380701 | Unknown status | Phase 1/Phase 2 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults | April 23, 2020 | April 2023 |
| NCT03776994 | Unknown status | Phase 1 | Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine | July 17, 2018 | April 2021 |
| NCT04365101 | Unknown status | Phase 1/Phase 2 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 | May 13, 2020 | June 30, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012327